Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds AGTC.
No tracked institution reports a position in AGTC as of their last filing.
No one on the platform has traded AGTC yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2022-11-21 | $-0.28 | $-0.28 | +0.0% |
| 2022-09-27 | $-0.34 | $-0.36 | -5.9% |
| 2022-05-16 | $-0.43 | $-0.33 | +23.3% |
| 2022-02-14 | $-0.38 | $-0.45 | -18.4% |
| 2021-11-09 | $-0.35 | $-0.40 | -14.3% |
| 2021-09-23 | $-0.40 | $-0.28 | +30.0% |
| 2021-05-17 | $-0.41 | $-0.40 | +2.4% |
| 2021-02-11 | $-0.59 | $-0.60 | -1.7% |
| $22M |
| — |
| FRLNFreeline Therapeutics Holdings plc | $6.49 | +0.15% | $28M | — |
| HARPHarpoon Therapeutics, Inc. | $23.01 | +0.09% | $865M | — |
Source: Financial Modeling Prep · peers by sector/industry
$AGTC I asked CGPT and he gave me following: Current AGTC CVR status: The first milestone (sale of certain assets within 18 months after the acquisition) has, based on current information, expired because no payment was made. Three milestones remain outstanding, each worth $0.1825 per CVR: (1) FDA approval of AGTC-501 (now laru-zova), (2) the First-to-Market bonus, provided that no competing RPGR gene therapy product receives FDA approval before laru-zova, and (3) achieving $100 million in annual net sales. Beacon Therapeutics continues to develop laru-zova. The registrational VISTA trial has been completed, with results expected in the second half of 2026. If the data are positive, there is still a possibility of future CVR payments.
View on StockTwits ↗
$AGTC PDUFA 3/28/26 Rocket Pharmaceuticals announced that clinical results for KRESLADI™ (in treating severe Leukocyte Adhesion Deficiency-I (LAD-I) remain overwhelmingly positive, with the therapy achieving all primary and secondary endpoints in its registration-enabling study. Key Study Results The global Phase 1/2 clinical trial (NCT03812263) involved nine pediatric patients with severe LAD-I and yielded the following results: Survival Rate: 100% overall survival at 12 months post-infusion, which has been sustained for all patients throughout the entire follow-up period (ranging from 18 to 45 months). Infection Reduction: A substantial decrease in the incidence of significant infections compared to the patients' pre-treatment histories. Clinical Improvements: Evidence of resolution of LAD-I-related skin and periodontal lesions, along with the restoration of wound-healing capabilities. The therapy was well-tolerated with zero drug-related serious adverse events
View on StockTwits ↗
$AGTC https://clarkstreetvalue.blogspot.com/2022/10/applied-genetic-technologies-no.html?m=1 Very good written
View on StockTwits ↗$AGTC Is there a time horizon on the CVR when they don't have to pay anything to us?
View on StockTwits ↗
$AGTC here there ! does anyone have any updates on the CVR payments ? or did receive already some ? thanks!
View on StockTwits ↗
@CABTC Please come check out @ $SPGC!! I have been following you since you told people about $MGOL $BHAT $AGTC $LICN Show a brother some love and take a few minutes, and check out $SPGC This is exactly what happened to MGOL before the rip!
View on StockTwits ↗
$AGTC https://www.beacontx.com/news-and-events/beacon-therapeutics-announces-positive-24-month-data-from-phase-2-skyline-trial-of-agtc-501-in-patients-with-x-linked-retinitis-pigmentosa/ Looks like the CVRs aren’t dead yet.
View on StockTwits ↗
$AGTC $AGTC how the fuq do I get this off my Robinhood account?
View on StockTwits ↗
$AMD $ARM $NVDA $AMZN $AGTC The market has been completely dead ! No movement at all in either direction.... stagnant ! Market Manipulators keeping assets subdued ?
View on StockTwits ↗
$AGTC, nadie nada del cobro de los hitos? yo intente buscar información y no encontré nada y me parece una vergüenza porque ya pasaron más de 18 meses y al menos deberían informarnos. Muchas gracias si alguien escribo por aquí si tiene alguna información.
View on StockTwits ↗$AGTC alguien sabe algo del pago del hito 1?
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.